| BCBS Oklahoma Medical Policies | Pozelimab-bbfg | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Progenitor Cell Therapy for the Treatment of Damaged | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Radiofrequency Ablation (RFA) of Primary or Metastatic Liver | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Radiofrequency Energy Therapy for Stress Urinary | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Radiofrequency Volumetric Tissue Reduction for Nasal | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Ranibizumab Injections, Implants and Biosimilars | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Ravulizumab-cwvz | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Reconstructive Breast Surgery | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Reconstructive Breast Surgery/Management of Breast | 2026-01-01 |
| BCBS Oklahoma Medical Policies | Reduction Mammaplasty for Breast-Related Symptoms | 2026-01-01 |